What is the prevalence of Hydranencephaly?
How many people does Hydranencephaly affect? Does it have the same prevalence in men and women? And in the different countries?
Hydranencephaly is a rare neurological condition characterized by the absence or severe underdevelopment of the cerebral hemispheres, which are the two large parts of the brain. It is estimated that the prevalence of Hydranencephaly is extremely low, affecting approximately 1 in every 10,000 to 25,000 live births. The condition is more commonly observed in infants and young children, and its exact cause remains unknown. Hydranencephaly can lead to significant developmental delays and neurological impairments. Early diagnosis and appropriate medical interventions are crucial in managing the condition and improving the quality of life for affected individuals.
Hydranencephaly is an extremely rare neurological condition characterized by the absence or severe underdevelopment of the cerebral hemispheres, the largest part of the brain. It is considered a congenital anomaly, meaning it is present at birth. The exact prevalence of hydranencephaly is difficult to determine due to its rarity and the lack of comprehensive data. However, it is estimated to occur in approximately 1 in 10,000 to 1 in 250,000 live births.
Hydranencephaly affects both males and females equally, and there is no known ethnic or geographic predisposition. The condition is typically diagnosed during infancy or early childhood, as the symptoms become apparent. These symptoms may include delayed development, seizures, abnormal muscle tone, vision and hearing impairments, and intellectual disabilities.
Unfortunately, there is no cure for hydranencephaly, and treatment primarily focuses on managing the symptoms and providing supportive care. The prognosis for individuals with hydranencephaly varies depending on the extent of brain damage and associated complications. Some individuals may have a limited lifespan, while others may survive into adulthood with significant disabilities.
